FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
Fudan University
Fudan University
Gruppo Oncologico del Nord-Ovest
Rutgers, The State University of New Jersey
The Affiliated Hospital of Qingdao University
University of Colorado, Denver
Affiliated Cancer Hospital of Shantou University Medical College
Fudan University
University Hospital of Split
University Hospital of Split
Udayana University
Fudan University
Hospital Civil de Guadalajara
Nova Scotia Health Authority
Zhongnan Hospital
Sir Run Run Shaw Hospital
The Institute of Molecular and Translational Medicine, Czech Republic
The Institute of Molecular and Translational Medicine, Czech Republic
The First Affiliated Hospital of Nanchang University
Tanta University
Ciusss de L'Est de l'Île de Montréal
Rush University Medical Center
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
McGill University Health Centre/Research Institute of the McGill University Health Centre
Helsinki University Central Hospital
Hospital Clinic of Barcelona
Yonsei University
Cedars-Sinai Medical Center
Kaohsiung Medical University Chung-Ho Memorial Hospital
Fudan University
Asan Medical Center
Amsterdam UMC, location VUmc
University Hospital, Limoges
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Erasmus Medical Center
Newcastle-upon-Tyne Hospitals NHS Trust
Grupo Espanol Multidisciplinario del Cancer Digestivo
Fudan University
China Meitan General Hospital
Kaunas University of Medicine
Nottingham University Hospitals NHS Trust
Federal University of Minas Gerais
Rabin Medical Center
Cantonal Hospital of St. Gallen
Ruijin Hospital
Maastricht University Medical Center
Nottingham University Hospitals NHS Trust
Hospital Universitario de Canarias
Johannes Gutenberg University Mainz
Fudan University
University of Rochester